Powder: -20°C for 3 years | In solvent: -80°C for 1 year
(S)-α-Methylbenzyl ricinoleamide is a fatty acid amide derived from ricinoleic acid and methyl benzylamine. It demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate (PC-3) cancer cells with a mean GI50 value of 6.9 μM.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
1 mg | 35 days | $ 78.00 | |
5 mg | 35 days | $ 348.00 | |
10 mg | 35 days | $ 595.00 | |
25 mg | 35 days | $ 1,330.00 |
Description | (S)-α-Methylbenzyl ricinoleamide is a fatty acid amide derived from ricinoleic acid and methyl benzylamine. It demonstrates potent growth inhibition of glioma (U251), breast (MCF-7), ovarian (NCI-ADR/RES and OVCAR-3), kidney (786-0), non-small cell lung (NCI-H460), and prostate (PC-3) cancer cells with a mean GI50 value of 6.9 μM. |
Molecular Weight | 401.63 |
Formula | C26H43NO2 |
CAS No. | 1246776-22-6 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMF: 30 mg/mL
Ethanol:PBS (pH 7.2) (1:3): 0.25 mg/mL
DMSO: 25 mg/mL
Ethanol: 30 mg/mL
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
(S)-α-Methylbenzyl Ricinoleamide 1246776-22-6 alpha-Methylbenzyl Ricinoleamide a-Methylbenzyl Ricinoleamide (S)αMethylbenzyl Ricinoleamide (S) α Methylbenzyl Ricinoleamide α-Methylbenzyl Ricinoleamide inhibitor inhibit